WNS Holdings

WNS Holdings, a Mumbai-headquartered business process management company listed on the NYSE, generated $809 million in annual revenue in fiscal 2019 (ending March 2019). The company's core verticals were insurance (its largest segment) and travel. Healthcare and life sciences represented a smaller share of total revenue. WNS recognized that its insurance-heavy revenue mix created cyclical concentration risk, while the global healthcare BPO market was growing at 10-12% annually, driven by payer complexity and regulatory burden. However, WNS lacked the clinical domain expertise and regulatory accreditations required to compete credibly for healthcare payer contracts. The company needed an acquisition to shortcut the 3-5 year organic build that healthcare BPO entry typically requires.

In March 2017, WNS acquired HealthHelp, a Houston-based care management company, for $95 million. HealthHelp brought three capabilities WNS could not have built organically in a reasonable timeframe:

• Clinical decision support platform: HealthHelp's proprietary Consult platform automated over 70% of clinical assessments and was backed by a peer-to-peer network of 100+ physicians and 11 university medical systems.
• Regulatory accreditations: HealthHelp held URAC and NCQA accreditation and Quality Improvement Organization (QIO)-like certification — prerequisites for serving US health plans that take years to obtain.
• Established payer relationships: HealthHelp's approximately 400 medical and operational professionals in the US already served major health plans, providing WNS immediate market access.

Following the acquisition, WNS integrated HealthHelp's capabilities into its broader BPM delivery model, combining HealthHelp's US-based clinical expertise with WNS's offshore delivery infrastructure. In April 2023, WNS reorganized from a geographic operating model into four strategic business units, establishing a dedicated Healthcare and Life Sciences (HCLS) vertical with its own P&L and leadership team.

The HealthHelp acquisition successfully expanded WNS's healthcare vertical, which grew to 17.7% of total company revenue by fiscal 2022 (ending March 2022), up from a smaller base pre-acquisition. With total revenue of $1,109.8 million in FY2022, the healthcare vertical contributed an estimated $196 million.

However, the healthcare vertical's share of revenue subsequently declined:

• FY2022: 17.7% of revenue (~$196M), on total revenue of $1,109.8M
• FY2023: 15.7% of revenue (~$192M), on total revenue of $1,224.3M
• FY2024: 13.4% of revenue (~$177M), on total revenue of $1,323.4M
• FY2025: 11.1% of revenue (~$146M), on total revenue of $1,314.9M

The FY2025 decline was partly driven by the loss of a large healthcare client, as disclosed in WNS's earnings release. While overall company revenue nearly doubled from $809M (FY2019) to $1,315M (FY2025), the healthcare vertical's contribution peaked in FY2022 and then contracted both in percentage and absolute terms.

The outcome illustrates a common pattern in acquisition-led market entry: the initial acquisition provides a credible foothold, but sustaining vertical growth requires continued organic investment and client diversification to avoid concentration risk within the new vertical.

• Overall company growth: Revenue grew from $809M (FY2019) to $1,315M (FY2025), a 63% increase over six fiscal years.
• Timeframe: Acquisition completed March 2017; peak healthcare contribution reached FY2022; subsequent decline through FY2025.

• WNS's existing insurance BPO expertise provided adjacent domain knowledge — claims processing and regulatory compliance workflows transferred to healthcare payer operations.
• India-based delivery model offered cost arbitrage for healthcare administrative functions that HealthHelp's US-based team could not provide alone.
• HealthHelp's URAC, NCQA, and QIO-like certifications provided immediate regulatory credibility with US health plans.
• HealthHelp's proprietary Consult platform, with 70%+ automated assessment processing, differentiated WNS from generic BPO competitors entering healthcare.